Rhea, a Singapore-based reproductive well being companies firm, raised follow-on funding of an undisclosed quantity.
The spherical was led by Thiel Capital, with participation from LifeX Ventures, Blue Lion World, and FJ Labs.
The corporate intends to make use of the funds to broaden its presence and repair choices in new markets.
Led by CEO Margaret Wang, Rhea is a contemporary international reproductive well being companies firm elevating fertility journeys for the fashionable household. Its scientific companies are delivered by Rhea’s GenPrime clinic community and a rising variety of associate clinics. The corporate’s clinic community is empowered by Rhea Labs, an built-in know-how platform leveraging the flywheel of accelerated time to market and quick product suggestions loop to enhance affected person outcomes.
Incubated and developed by Recharge Capital, Rhea serves markets throughout Asia with extra operations in North America and Europe.
FinSMEs
03/06/2024
